Biologics Upstream Specialist – Tech Transfer

100 Eli Lilly and Company; United States; Presencial; USD 68.000 - 174.000; Jornada completa

Ventajas ofrecidas por este puesto de trabajo

401(k) plan

Pension

Vacation benefits

Medical benefits

Dental benefits

Vision benefits

Descripción de la vacante

Lilly is seeking passionate and agile scientists to join the Process Translation and Execution (PTE) team to help realize the Lilly Medicines Foundry vision in Indiana. The role focuses on transferring biologics manufacturing processes from development to production, performing scale‑up studies, and ensuring readiness for early‑phase cGMP API manufacturing for clinical supply.

Initial location is at Lilly Technology Center-North in Indianapolis with potential move to Lebanon, Indiana.

Formación

• B.S./M.S. in Chemical/Biochemical Engineering or related disciplines is required.
• 5+ years of biologics upstream and/or manufacturing API experience.
• Authorized to work in the United States on a full-time basis.

Responsabilidades

• Evaluate and facilitate transfer of biologics manufacturing processes from development to manufacturing.
• Perform lab work to generate data supporting tech transfer and troubleshoot operations.
• Conduct scale‑down/scale‑up studies to ensure plant readiness and evaluate new tech.
• Author and review technical documents including tech transfer plans, SOPs, batch records, and deviation reports.

Conocimientos

Biologics upstream experience

Manufacturing API familiarity

Data analysis and presentation

cGMP knowledge

Educación

B.S./M.S. in Chemical/Biochemical Engineering or related disciplines

Herramientas

HPLC/UPLC

Scale-up/tech transfer

Descripción del empleo

Lilly is seeking passionate and agile scientists to join the Process Translation and Execution (PTE) team to help realize the Lilly Medicines Foundry vision in Indiana. The role focuses on transferring biologics manufacturing processes from development to production, performing scale‑up studies, and ensuring readiness for early‑phase cGMP API manufacturing for clinical supply.

Initial location is at Lilly Technology Center-North in Indianapolis with potential move to Lebanon, Indiana.